Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Events Among Adults Patients With Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell Therapy: A Single-Institution Experience

NCT04870853 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT04870853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04870853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Events Among Adults Patients With Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell Therapy: A Single-Institution Experience
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Unknown status
Start date
April 2, 2020
Completion date
January 30, 2025
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent aggressive b-cell non-hodgkin lymphoma, recurrent diffuse large b-cell lymphoma, recurrent high grade b-cell lymphoma, recurrent primary mediastinal (thymic) large b-cell lymphoma, recurrent transformed follicular lymphoma to diffuse large b-cell lymphoma, refractory aggressive b-cell non-hodgkin lymphoma, refractory diffuse large b-cell lymphoma, refractory high grade b-cell lymphoma, refractory primary mediastinal (thymic) large b-cell lymphoma, refractory transformed follicular lymphoma to diffuse large b-cell lymphoma